All of the following are true about CRASH-2 trial except:
CRASH-2 TRIAL* Recommends use of Tranexamic acid in hypotensive trauma patients* 1 gm I/V over 10 minutes followed by 1 gm over 8 hours* Advantages- Reduces the risk of moality from bleeding in both blunt & penetrating trauma* Indications for Tranexamic acid- All trauma patients suspected to have significant hemorrhage including SBP < 110 mmHg or PR > 110/min- Administrated within 3 hours of injury
Trauma
Dose of tranexamic acid is 1 gm IV over 10 minutes followed by 1 gm over 8 hours
Given to all trauma patients suspected to have significant hemorrhage including SBP <110 mm Hg or PR >110/min
Should be administered within 3 hours of injury
Tranexamic acid reduces the risk of moality from bleeding in blunt trauma but not in penetrating trauma
Tranexamic acid reduces the risk of moality from bleeding in blunt trauma but not in penetrating trauma